Approval · Notice of Compliance 24865 · 2020
VPRIV: Notice of Compliance 24865
Issued December 21, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24865
- Date
- December 21, 2020
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Transfer of drug identification number. labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VPRIV | Not yet assigned | — |
Medicinal ingredients
- VELAGLUCERASE ALFA 400 UNIT per VIAL